Biosurgery Market Plying for Significant Growth During 2017 2023

Posted by sagar on February 17th, 2021

Market Highlights

Biosurgery Market products are used in numerous surgical procedures to minimize intra- and post-operative complications. The increasing geriatric population, a growing number of surgical procedures, rising occurrences of trauma and sports-related injuries are the major factors driving the growth of the global biosurgery market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in March 2015, Kuros Biosurgery announced the grant of a US patent for its synthetic hydrogel technology which is a combination of bioactive and biomaterial products such as sealants and orthobiologics.

The high costs associated with surgeries, stringent regulatory environment for product approval, and increasing popularity of minimally invasive surgeries are likely to hinder market growth during the forecast period.

Regional Analysis

The market in the Americas is expected to dominate the global biosurgery market during the forecast period owing to the increasing prevalence of chronic diseases along with the growing geriatric population, rising occurrences of injuries, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, coupled with increasing research and development. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global biosurgery market. The market growth in this region can be attributed to increasing healthcare expenditure and low manufacturing costs of pharmaceuticals.

Segmentation

The global biosurgery market has been segmented on the basis of product, source, and application.

On the basis of product, the market has been classified as bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The bone-graft substitutes segment has been further divided into demineralized bone matrix, synthetic bone grafts, bone morphogenetic proteins, and other bone-graft substitutes. The hemostatic agents segment has been further divided into thrombin-based hemostatic agents, oxidized regenerated cellulose-based hemostatic agents, and combination hemostatic agents. The soft-tissue attachments segment has been classified as synthetic meshes and biological meshes. The surgical sealants and adhesives segment has been divided into natural and synthetic sealants and adhesives. The natural sealants sub-segment has been segmented into fibrin sealants, collagen-based sealants, gelatin-based sealants, albumin-based sealants, and other natural sealants. The synthetic sealants segment has been divided into peg hydrogels, cyanoacrylate-based sealants and adhesives, urethane-based sealants and adhesives, and others. Furthermore, the adhesion barriers segment has been sub-segmented into synthetic and natural adhesion barriers. The synthetic adhesion barriers segment includes hyaluronic acid-based, peg-based, and ther synthetic barriers. The natural adhesion barriers segment includes collagen- and fibrin-based adhesion barriers.

The market, by source, has been segmented into biological and natural products. On basis of application, the market has been divided into neurological surgery, general surgery, cardiovascular surgery, orthopedic surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and urology surgery.

Key Players

Some of the key players in the global biosurgery market are Baxter International, Inc., B. Braun Melsungen AG, C.R. Bard, Johnson & Johnson, Medtronic, PLC., MAQUET Holding B.V. & Co. Kg. (Getinge Group), Cohera Medical Inc., Integra Lifesciences Holdings Corporation, Commonwealth Serum Laboratories (CSL), Hemostasis, LLC, Sanofi, Pfizer Inc., Stryker Corporation, Cryolife, Inc., and Kuros Biosciences Ltd.


sagar

About the Author

sagar
Joined: January 27th, 2020
Articles Posted: 321

BitKong: Fairest and most thrilling Bitcoin casino on the market
Win serious funds fast when you stack the BitKong bonus combo, cash in on the referral program, or hit the massive jackpot then walk away with your life changed.
Dualmine - Multiply your Bitcoin, Ethereum, Litecoin and Dogecoin
Start cloud mining and increase your crypto capital now! Unique product offering the mining of the most profitable cryptocurrencies in the cloud - BTC and ETH. You can mining one of them or both at the same time. Your hardware is already running and waiti
Pool by Cake - Get cash flow from cryptocurrencies
The most transparent way to put your Bitcoin and other cryptocurrencies to work.
7Bit Casino
Exciting online casino that accepts Bitcoin and Ethereum! Play all of your favorite games including poker, roulette, blackjack, baccarat, slot machines and more!
Cointiply Bitcoin Faucet - Earn Free Bitcoin
Earn free Bitcoin from the best Bitcoin faucet & rewards platform. Complete offers & surveys, watch videos & play games to earn even more Bitcoin.
HORIZEN FAUCET
Get free ZEN through the Horizen faucet. Our faucet is a great way to receive free rewards and begin your journey into the world of cryptocurrency. Start earning now.